The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact

Submitted: May 3, 2020
Accepted: May 13, 2020
Published: May 19, 2020
Abstract Views: 1288
PDF: 738
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

SARS-CoV-2 infection, responsible for COVID-19, can determine cardiac events, which require a quick diagnosis and management, and should not be overlooked due to the presence of COVID-19 infection. In some cases, cardiovascular symptoms can also be the first and only manifestation of SARS-CoV-2 infection. In patients with COVID-19, the full cardiovascular disease diagnostic algorithm can be hindered by logistic restrain mainly derived from the difficulty of transporting patients in critical conditions to Radiology or Hemodynamics wards. The echocardiography in SARS-CoV-2 pandemic can help for differential diagnosis of cardiac events, which can be related or unrelated by the infection and can likely impact on short-term prognosis. Indeed, transthoracic echocardiography plays a key role in the screen for CV complications of COVID-19 infection: it must be focused cardiac ultrasound study (FoCUS) performed at bedside. All transthoracic, transesophageal and stress echocardiograms in patients in which test results are unlikely to change the management strategy should be postponed.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Pacileo, Mario, Francesco Giallauria, Cristina Savarese, Teresa Cirillo, Fabio Crescibene, Anna Di Lorenzo, Mariacarla Ferrillo, Maria Grazia Calabrese, Carlo Vigorito, and Antonello D’Andrea. 2020. “The Role of Echocardiography in SARS-CoV-2 Pandemic: A Compromise Among Appropriateness, Safety and Clinical Impact”. Monaldi Archives for Chest Disease 90 (2). https://doi.org/10.4081/monaldi.2020.1358.